Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Women's Issues in Multiple Sclerosis.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Dimethylfumarate induces apoptosis in human mast cells.
World Congress of Neurology (WCN) 2015
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
8th Annual Symposium on Glial-Neuronal Interactions
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Neurovascular and Immuno-Imaging Symposium
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS

Pages